Study of Sitagliptin in Older Type 2 Diabetics (0431-047)(COMPLETED)

NCT00305604 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

206

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: sitagliptin phosphate
DRUG: Comparator: Placebo

Sponsor

Merck Sharp & Dohme LLC